Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 2055 | 44.1 |
09:36 ET | 4650 | 44.115 |
09:38 ET | 3484 | 44.61 |
09:39 ET | 2821 | 44.4226 |
09:41 ET | 930 | 44.215 |
09:43 ET | 1771 | 44.1506 |
09:45 ET | 1100 | 43.76 |
09:48 ET | 1100 | 43.925 |
09:50 ET | 6662 | 43.975 |
09:52 ET | 800 | 43.74 |
09:54 ET | 1000 | 43.815 |
09:56 ET | 300 | 43.895 |
09:57 ET | 1162 | 43.97 |
09:59 ET | 5161 | 44.15 |
10:01 ET | 100 | 44.26 |
10:03 ET | 310 | 44.34 |
10:06 ET | 3227 | 44.13 |
10:08 ET | 3514 | 44.195 |
10:10 ET | 2103 | 44.08 |
10:12 ET | 4886 | 43.935 |
10:14 ET | 2218 | 44.2392 |
10:15 ET | 500 | 44.255 |
10:17 ET | 300 | 44.4 |
10:19 ET | 3512 | 44.4821 |
10:21 ET | 400 | 44.62 |
10:24 ET | 200 | 44.61 |
10:26 ET | 3792 | 44.7 |
10:28 ET | 818 | 44.545 |
10:30 ET | 100 | 44.53 |
10:32 ET | 500 | 44.56 |
10:33 ET | 100 | 44.64 |
10:37 ET | 1110 | 44.75 |
10:39 ET | 2300 | 44.8351 |
10:42 ET | 2438 | 44.85 |
10:44 ET | 600 | 44.89 |
10:46 ET | 1709 | 44.94 |
10:48 ET | 1610 | 44.975 |
10:50 ET | 2200 | 44.99 |
10:51 ET | 1100 | 45 |
10:53 ET | 2400 | 45.11 |
10:55 ET | 1650 | 45.155 |
10:57 ET | 1500 | 44.96 |
11:00 ET | 880 | 45.07 |
11:02 ET | 1467 | 45 |
11:04 ET | 2216 | 44.79 |
11:06 ET | 1150 | 44.79 |
11:08 ET | 1687 | 44.84 |
11:09 ET | 10402 | 44.47 |
11:11 ET | 3155 | 44.37 |
11:13 ET | 1391 | 44.34 |
11:15 ET | 500 | 44.235 |
11:18 ET | 500 | 44.25 |
11:20 ET | 1700 | 44.49 |
11:22 ET | 1925 | 44.49 |
11:24 ET | 100 | 44.405 |
11:26 ET | 300 | 44.43 |
11:27 ET | 400 | 44.43 |
11:29 ET | 500 | 44.52 |
11:31 ET | 300 | 44.54 |
11:33 ET | 200 | 44.485 |
11:36 ET | 504 | 44.42 |
11:38 ET | 100 | 44.48 |
11:40 ET | 15919 | 44.56 |
11:42 ET | 200 | 44.5 |
11:44 ET | 1350 | 44.315 |
11:45 ET | 884 | 44.298 |
11:49 ET | 900 | 44.07 |
11:51 ET | 110 | 44.14 |
11:54 ET | 860 | 44.15 |
11:56 ET | 700 | 44.1 |
11:58 ET | 146 | 44.13 |
12:00 ET | 1100 | 44.2477 |
12:02 ET | 1650 | 44.1075 |
12:03 ET | 500 | 44.07 |
12:05 ET | 7132 | 44.0432 |
12:07 ET | 1505 | 44.05 |
12:09 ET | 3848 | 44.01 |
12:12 ET | 2399 | 44.17 |
12:14 ET | 1400 | 44.42 |
12:16 ET | 800 | 44.38 |
12:18 ET | 200 | 44.375 |
12:20 ET | 401 | 44.38 |
12:21 ET | 100 | 44.42 |
12:23 ET | 700 | 44.255 |
12:25 ET | 600 | 44.305 |
12:30 ET | 400 | 44.22 |
12:32 ET | 2700 | 43.9 |
12:34 ET | 4944 | 43.94 |
12:36 ET | 3263 | 43.98 |
12:38 ET | 2604 | 43.8 |
12:39 ET | 16144 | 43.99 |
12:41 ET | 900 | 44 |
12:43 ET | 1320 | 44.095 |
12:45 ET | 3300 | 44 |
12:48 ET | 6510 | 43.86 |
12:50 ET | 2600 | 43.8 |
12:52 ET | 3700 | 43.67 |
12:54 ET | 5353 | 43.71 |
12:56 ET | 11740 | 43.7 |
12:57 ET | 1049 | 43.695 |
12:59 ET | 600 | 43.68 |
01:01 ET | 7859 | 43.48 |
01:03 ET | 13520 | 43.595 |
01:06 ET | 13075 | 43.535 |
01:08 ET | 6962 | 43.5 |
01:10 ET | 1700 | 43.475 |
01:12 ET | 500 | 43.475 |
01:14 ET | 6105 | 43.09 |
01:15 ET | 13609 | 42.99 |
01:17 ET | 2100 | 43 |
01:19 ET | 4800 | 43.05 |
01:21 ET | 2800 | 43.12 |
01:24 ET | 2100 | 43.15 |
01:26 ET | 2098 | 43.17 |
01:30 ET | 200 | 43.135 |
01:32 ET | 750 | 42.83 |
01:33 ET | 500 | 42.9482 |
01:35 ET | 1252 | 42.9 |
01:37 ET | 12248 | 43.03 |
01:39 ET | 852 | 43 |
01:42 ET | 1043 | 43.06 |
01:44 ET | 900 | 43 |
01:46 ET | 4832 | 43.025 |
01:48 ET | 8035 | 43.04 |
01:50 ET | 350 | 43.04 |
01:51 ET | 7557 | 43.065 |
01:53 ET | 1611 | 43.07 |
01:55 ET | 1000 | 43.14 |
01:57 ET | 2541 | 42.9 |
02:00 ET | 1870 | 42.94 |
02:02 ET | 1501 | 42.64 |
02:04 ET | 1000 | 42.57 |
02:06 ET | 6110 | 42.48 |
02:08 ET | 4095 | 42.38 |
02:09 ET | 6428 | 42.44 |
02:11 ET | 11215 | 42.37 |
02:13 ET | 3837 | 42.27 |
02:15 ET | 4462 | 42.3 |
02:18 ET | 5237 | 42.29 |
02:20 ET | 2301 | 42.32 |
02:22 ET | 3875 | 42.38 |
02:24 ET | 18873 | 42.68 |
02:26 ET | 1396 | 42.64 |
02:27 ET | 5322 | 42.77 |
02:29 ET | 2554 | 42.545 |
02:31 ET | 5244 | 42.585 |
02:33 ET | 4175 | 42.48 |
02:36 ET | 1790 | 42.44 |
02:38 ET | 2039 | 42.54 |
02:40 ET | 11940 | 42.53 |
02:42 ET | 1600 | 42.46 |
02:44 ET | 1630 | 42.42 |
02:45 ET | 3200 | 42.42 |
02:47 ET | 5900 | 42.47 |
02:49 ET | 24813 | 42.8 |
02:51 ET | 12276 | 43.06 |
02:54 ET | 4939 | 43.04 |
02:56 ET | 2455 | 43.085 |
02:58 ET | 2140 | 43.145 |
03:00 ET | 12010 | 43.285 |
03:02 ET | 5979 | 43.02 |
03:03 ET | 7025 | 42.975 |
03:05 ET | 9133 | 42.975 |
03:07 ET | 12099 | 42.955 |
03:09 ET | 8747 | 42.955 |
03:12 ET | 9878 | 43.005 |
03:14 ET | 5001 | 43.01 |
03:16 ET | 17094 | 43.23 |
03:18 ET | 1300 | 43.15 |
03:20 ET | 3562 | 43.01 |
03:21 ET | 6400 | 43.01 |
03:23 ET | 5215 | 42.82 |
03:25 ET | 7155 | 42.725 |
03:27 ET | 6239 | 42.76 |
03:30 ET | 3859 | 42.685 |
03:32 ET | 9968 | 42.595 |
03:34 ET | 8512 | 42.4 |
03:36 ET | 7603 | 42.25 |
03:38 ET | 1357 | 42.245 |
03:39 ET | 3379 | 42.22 |
03:41 ET | 16394 | 42.25 |
03:43 ET | 11633 | 42.27 |
03:45 ET | 10711 | 42.25 |
03:48 ET | 17708 | 42.245 |
03:50 ET | 25752 | 41.925 |
03:52 ET | 13694 | 41.89 |
03:54 ET | 28331 | 41.53 |
03:56 ET | 22291 | 41.74 |
03:57 ET | 22003 | 41.61 |
03:59 ET | 95858 | 41.95 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.5B | -18.7x | --- |
Immunitybio Inc | 2.5B | -3.8x | --- |
Vera Therapeutics Inc | 2.6B | -20.4x | --- |
Janux Therapeutics Inc | 2.5B | -52.3x | --- |
CG Oncology Inc | 2.4B | -31.0x | --- |
Edgewise Therapeutics Inc | 2.4B | -16.9x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -18.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.